Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02673229 · ClinicalTrials.gov registry record · Phase 4
Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns
A Phase 4 study, sponsored by University of Kansas Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT02673229 is a Phase 4 study that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT02673229, a Phase 4 study, was terminated before completion, sponsored by University of Kansas Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
By doing this study, researchers hope to learn if applying Santyl to the burn during the healing process affects the appearance of the resulting scar.
Interventions
- DRUG Bacitracin
- DRUG Collagenase Santyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-09-30 |
| Est. Completion | 2020-03-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02673229
The ClinicalTrials.gov registry entry for NCT02673229 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bacitracin is the first listed.
NCT02673229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02673229 about?
NCT02673229 is a clinical study titled "Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns". By doing this study, researchers hope to learn if applying Santyl to the burn during the healing process affects the appearance of the resulting scar.
What is the current status of trial NCT02673229?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2013-09-30. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT02673229?
The interventions under investigation include: Bacitracin (DRUG), Collagenase Santyl (DRUG).
Who is sponsoring clinical trial NCT02673229?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.